SKIN forecast price prediction

SKIN price prediction: 2027, 2030, 2040

The honest answer

K3vl4r forecasts short horizons (up to about a week ahead), so we don't publish a single 2040 price for SKIN — no model can honestly do that. What we can say: SKIN currently trades near $0.7258, the model reads it as 3/4 bullish near-term (top short-horizon projection ~$8.20), and below is the annualized growth SKIN would need to reach each milestone by 2027, 2030, 2040. These are scenarios, not predictions, and not financial advice.

What our model forecasts now

K3vl4r reads SKIN as 3/4 bullish across its 1-hour to 1-week horizons, with a top short-horizon projection near $8.20. This is the only part that is an actual model forecast — see the full SKIN forecast.

Longer-term scenarios (2027, 2030, 2040)

Not model forecasts — the compound annual growth SKIN would need from today's $0.7258 to reach each target by year-end. Simple math, honestly labelled.

Targetby 2027by 2030by 2040
$1.00+24.0%/yr+7.4%/yr+2.2%/yrdetails →
$2.00+97.2%/yr+25.3%/yr+7.2%/yrdetails →
$3.00+159%/yr+37.1%/yr+10.3%/yrdetails →
$5.00+264%/yr+53.7%/yr+14.2%/yrdetails →

FAQ

What is SKIN's price prediction for 2040?

We don't publish a single SKIN price for 2040 — our AI model forecasts short horizons, and honest long-range point predictions aren't possible. As a scenario, reaching $1.00 by 2040 would require about +2.2%/yr from today's $0.7258. The model's current near-term read is 3/4 bullish.

Will SKIN go up in 2027?

K3vl4r's model currently reads SKIN as 3/4 bullish across its 1-hour to 1-week horizons. That's a near-term signal, not a full-year prediction — see the live forecast for the latest.

How is this generated? Read how K3vl4r forecasts, compare tools in our AI forecasting guide, or see the live SKIN forecast.

Forecasts are model-generated estimates for informational purposes only and are not financial advice. Long-range figures are arithmetic scenarios, not predictions. Markets are risky; past patterns do not guarantee future prices. See our Risk Disclosure.